Teslas Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 25.05%
- Profit Growth 60.27%
- Ebitda 27.29%
- Net Worth 7.85%
- Total Assets 13.69%
About Teslas Pharma
Teslas Pharma Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 May 2017 (Seven years and eight months 4 days old ). Its registered office is in Raipur, Chattisgarh, India.
The Corporate was formerly known as Trinetri It Corporation Private Limited. The Company is engaged in the Wood Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Dwivedi and Neeraj Agrawal serve as directors at the Company.
Company Details
-
Location
Raipur, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36100CT2017PTC007976
-
Company No.
007976
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Teslas Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Dwivedi
|
Director | 30-May-2017 | Current |
|
Neeraj Agrawal
|
Director | 05-Jun-2020 | Current |
Financial Performance of Teslas Pharma.
Teslas Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 25.05% increase. The company also saw a substantial improvement in profitability, with a 60.27% increase in profit. The company's net worth moved up by a moderate rise of 7.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Teslas Pharma?
Unlock access to Teslas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Healthynature Agro Private LimitedRavindra Dwivedi is a mutual person
-
Kalyanswarup Jewellers Private Limited
Ravindra Dwivedi is a mutual person
-
Aspire Infrabuild India Private Limited
Ravindra Dwivedi is a mutual person
-
Vimal Shree Foundation
Ravindra Dwivedi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Teslas Pharma?
Unlock and access historical data on people associated with Teslas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Teslas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teslas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
